Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (531-540 of 715) with videos related to

Pageof 72
Sort By:
Thrombosis and Haemostasis|March 30, 2000
Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in miceM Dewerchin, Z Liang, L Moons, et al.
Journal of Virology|June 1, 1984
Multiple proteases in foot-and-mouth disease virus replicationJ N Burroughs, D V Sangar, B E Clarke, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient miceT VandenDriessche, V Vanslembrouck, I Goovaerts, et al.
Human Gene Therapy|April 11, 2000
Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient miceM K Chuah, A Van Damme, H Zwinnen, et al.
The American Journal of Cardiology|October 1, 1986
Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosisH D Garabedian, H K Gold, R C Leinbach, et al.
Neuroscience Letters|August 28, 1999
Nigral degeneration following striato-pallidal lesion in tissue type plasminogen activator deficient miceK Kataoka, T Asai, M Taneda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2000
Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesityP E Morange, H R Lijnen, M C Alessi, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[Low molecular weight heparin CY 222 (Choay) potentiates the thrombolytic effect of 1-PA in rabbits with experimental thrombosis of the jugular vein]I Juhan-Vague, J M Stassen, M C Alessi, et al.
European Journal of Biochemistry|April 1, 1995
Structural domains of streptokinase involved in the interaction with plasminogenP Rodríguez, P Fuentes, M Barro, et al.
Blood|January 15, 1992
Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1X K Li, H R Lijnen, L Nelles, et al.
Pageof 72

Showing results (531-540 of 715) with videos related to

Sort By:
Pageof 72
Thrombosis and Haemostasis|March 30, 2000
Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in miceM Dewerchin, Z Liang, L Moons, et al.
Journal of Virology|June 1, 1984
Multiple proteases in foot-and-mouth disease virus replicationJ N Burroughs, D V Sangar, B E Clarke, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient miceT VandenDriessche, V Vanslembrouck, I Goovaerts, et al.
Human Gene Therapy|April 11, 2000
Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient miceM K Chuah, A Van Damme, H Zwinnen, et al.
The American Journal of Cardiology|October 1, 1986
Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosisH D Garabedian, H K Gold, R C Leinbach, et al.
Neuroscience Letters|August 28, 1999
Nigral degeneration following striato-pallidal lesion in tissue type plasminogen activator deficient miceK Kataoka, T Asai, M Taneda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2000
Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesityP E Morange, H R Lijnen, M C Alessi, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[Low molecular weight heparin CY 222 (Choay) potentiates the thrombolytic effect of 1-PA in rabbits with experimental thrombosis of the jugular vein]I Juhan-Vague, J M Stassen, M C Alessi, et al.
European Journal of Biochemistry|April 1, 1995
Structural domains of streptokinase involved in the interaction with plasminogenP Rodríguez, P Fuentes, M Barro, et al.
Blood|January 15, 1992
Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1X K Li, H R Lijnen, L Nelles, et al.
Pageof 72